A Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies

Clinical trial NCT03522142 · TERMINATED

Trial details

NCT number: NCT03522142
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2018-08-27
Primary completion: 2025-09-10
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.